Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MVD | P53602 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fosfocreatine SCHEMBL24116748 | 1.00 | MVD (0.44) | MVD | |
| Fosfocreatine SCHEMBL2124030 | 1.00 | MVD (0.44) | MVD | |
| Fosfocreatine SCHEMBL2635002 | 0.98 | MVD (0.42) | MVD | |
| Fosfocreatine SCHEMBL5248692 | 0.92 | MVD (0.39) | MVD | |
| Fosfocreatine SCHEMBL9075223 | 0.92 | MVD (0.39) | MVD | |
| Fosfocreatine SCHEMBL453327 | 0.90 | MVD (0.38) | MVD | |
| Fosfocreatine SCHEMBL29526710 | 0.89 | MVD (0.37) | MVD | |
| Fosfocreatine SCHEMBL29749874 | 0.82 | MVD (0.40) | MVD | |
| Fosfocreatine SCHEMBL1640494 | 0.81 | MVD (0.38) | MVD | |
| Fosfocreatine SCHEMBL30031412 | 0.81 | MVD (0.38) | MVD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 8252 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| US-20260124165-A1 | COMPOSITIONS COMPRISING CREATINE FOR USE IN TELOMERE LENGTHENING | OSTOJIC SERGEJ (RS) | 2026-05-07 | — | — | US | claimed |
| US-20260115293-A1 | METHODS AND COMPOSITIONS FOR PREVENTION AND TREATMENT OF ACUTE RADIATION SYNDROMES (ARS) | MAROON BIOTECH CORP (US) | 2026-04-30 | — | — | US | claimed |
| EP-4713704-A1 | MAGNETIC RESONANCE METHOD, COMPUTER PROGRAM PRODUCT AND MAGNETIC RESONANCE IMAGING MACHINE | Università degli Studi di Torino (IT) | 2026-03-25 | — | — | EP | claimed |
| EP-4709434-A1 | CALCIUM PHOSPHATE POWDER COMPOSITION | Biomimetic Innovations Limited (IE) | 2026-03-18 | — | — | EP | claimed |
| US-12543767-B2 | Oral supplements containing enriched phenolic compound extracts combined with organic acid sodium salts, creatines and/or creatine salts | PHENOLICS, LLC | 2026-02-10 | — | — | US | claimed |
| EP-3644959-B1 | COMPOSITION COMPRISING CHOLINE, SUCCINATE AND NICOTINAMIDE AND ITS USE IN BRAIN ENERGY METABOLISM | MITOCHOLINE LTD (GB) | 2025-12-10 | — | — | EP | claimed |
| EP-4620491-A1 | COMPRESSED TABLET OF CALCIUM PHOSPHATE | Biomimetic Innovations Limited (IE) | 2025-09-24 | — | — | EP | claimed |
| US-12390425-B1 | Use of tyrosol as a physiological enhancer of creatine and its application in continuous high intensity exercise | MolTek Nutrition Co., Ltd (CN) | 2025-08-19 | — | — | US | claimed |
| EP-4596717-A2 | RECOMBINASE POLYMERASE AMPLIFICATION REAGENTS AND KITS | Abbott Diagnostics Scarborough, Inc. (US) | 2025-08-06 | — | — | EP | claimed |
| US-4981136-A | Nuclear magnetic resonance apparatus for evaluating muscle efficiency and maximum power of muscle of a living animal | PERFORMANCE PREDICTIONS, INC. (US) | 1991-01-01 | — | — | US | claimed |
| EP-0150883-B1 | PROCESS FOR PREPARING N-(DIBENZYLOXYPHOSPHORYL)-CYANAMIDE AND PROCESSES USING SAID COMPOUNDS AS INTERMEDIATE FOR THE SYNTHESIS OF PHOSPHAGEN SUBSTANCES | F.I.S. FABBRICA ITALIANA SINTETICI S.p.A. (IT) | 1989-04-19 | — | — | EP | claimed |
| US-4675314-A | INFUSION SOLUTION FOR ACUTE MYOCARDIAL INFACTION AND MYOCARDI UM PROTECTING AGENT DURING SURGERY | SCHIAPPARELLI FARMACEUTICI S.P.A. (IT) | 1987-06-23 | — | — | US | claimed |
| US-4656133-A | Method for enzymatic synthesis of isotopically labeled carbohydrates | BOARD OF REGENTS, UNIVERSITY OF TEXAS SYSTEM (US) | 1987-04-07 | — | — | US | claimed |
| US-4620543-A | Enhanced fracture healing and muscle exercise through defined cycles of electric stimulation | RICHARDS MEDICAL COMPANY (US) | 1986-11-04 | — | — | US | claimed |
| EP-0199117-A2 | New therapeutical use of phosphocreatine | SCHIAPPARELLI FARMACEUTICI S.p.A. (IT) | 1986-10-29 | — | — | EP | claimed |
| EP-0084169-B1 | METHOD FOR THE ORAL ADMINISTRATION OF SUBSTANCES IN THE FORM OF LIPOSOMES, AND RELATIVE PHARMACEUTICAL COMPOSITIONS | AUSONIA FARMACEUTICI S.r.l. (IT) | 1985-09-04 | — | — | EP | claimed |
| EP-0150883-A2 | Process for preparing N-(dibenzyloxyphosphoryl)-cyanamide and processes using said compounds as intermediate for the synthesis of phosphagen substances | F.I.S. FABBRICA ITALIANA SINTETICI S.p.A. (IT) | 1985-08-07 | — | — | EP | claimed |
| US-4441502-A | NMR System for determining relationship between work output and oxidative phosphorylation capability in an exercising body member | OTSUKA ELECTRONICS (U.S.A.) INC. | 1984-04-10 | — | — | US | claimed |
| EP-0084169-A1 | Method for the oral administration of substances in the form of liposomes, and relative pharmaceutical compositions | AUSONIA FARMACEUTICI S.r.l. (IT) | 1983-07-27 | — | — | EP | claimed |